Australian Regulator Asks Companies To Suggest Improvements To Proposed Advertising Code
Executive Summary
Just weeks after introducing tougher sanctions and penalties in Australia for healthcare product advertising breaches, the
You may also be interested in...
'Reasonable Consumer' Concept Clarified In Revised Australian Advertising Guide
A second draft of the guideline has been issued for consultation as stakeholders prepare for compliance with the new Therapeutic Goods Advertising Code that is due to apply next year.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.